Position in VTRS
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$19,657
+$1,705 QoQ
Shares Held
1,455
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Silicon Valley Capital Partners holds $21,325 across 5 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (92.2% of the industry book) .
All Filings in VTRS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,657 | 1,455 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $17,952 | 1,442 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,137 | 1,428 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $12,600 | 1,411 | Shares | Sole | 2025-09-11 | |
| 2025-03-31 | $12,124 | 1,392 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $17,106 | 1,374 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $15,812 | 1,362 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $14,329 | 1,348 | Shares | Sole | 2024-10-30 | |
| 2024-03-31 | $15,916 | 1,333 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $790 | 73 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $709 | 72 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $708 | 71 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $683 | 71 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $779 | 70 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||